Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy

JAMA. 2018 Oct 9;320(14):1485-1486. doi: 10.1001/jama.2018.13998.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Atrial Fibrillation / drug therapy
  • Blood Coagulation Tests*
  • Factor Xa Inhibitors / adverse effects
  • Factor Xa Inhibitors / blood*
  • Factor Xa Inhibitors / pharmacology
  • Factor Xa Inhibitors / therapeutic use
  • Hematoma, Subdural / chemically induced*
  • Hemorrhage / prevention & control
  • Humans
  • Male
  • Prothrombin Time
  • Rivaroxaban / adverse effects
  • Rivaroxaban / blood*
  • Rivaroxaban / therapeutic use

Substances

  • Factor Xa Inhibitors
  • Rivaroxaban